[go: up one dir, main page]

NO20002450D0 - Sammenstilling av aktive bestanddeler, særlig tetrahydropyridiner og acetylcholinesterase-inhiberende midler, for Õ behandle senil demens av type Alzheimer - Google Patents

Sammenstilling av aktive bestanddeler, særlig tetrahydropyridiner og acetylcholinesterase-inhiberende midler, for Õ behandle senil demens av type Alzheimer

Info

Publication number
NO20002450D0
NO20002450D0 NO20002450A NO20002450A NO20002450D0 NO 20002450 D0 NO20002450 D0 NO 20002450D0 NO 20002450 A NO20002450 A NO 20002450A NO 20002450 A NO20002450 A NO 20002450A NO 20002450 D0 NO20002450 D0 NO 20002450D0
Authority
NO
Norway
Prior art keywords
tetrahydropyridines
compilation
alzheimer
treatment
active ingredients
Prior art date
Application number
NO20002450A
Other languages
English (en)
Other versions
NO20002450L (no
Inventor
Jean-Pierre Maffrand
Philippe Soubrie
Jean-Paul Terranova
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714324A external-priority patent/FR2771006B1/fr
Priority claimed from FR9714322A external-priority patent/FR2771007B1/fr
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20002450D0 publication Critical patent/NO20002450D0/no
Publication of NO20002450L publication Critical patent/NO20002450L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20002450A 1997-11-14 2000-05-11 Sammenstilling av aktive bestanddeler, særlig tetrahydropyridiner og acetylcholinesterase-inhiberende midler, for behandling av senil demens av Alzheimer-type NO20002450L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714324A FR2771006B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR9714322A FR2771007B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
PCT/FR1998/002384 WO1999025363A1 (fr) 1997-11-14 1998-11-09 Association de principes actifs, notamment de tetrahydropyridines et d'agents inhibiteurs de l'acetylcholinesterase, pour le traitement de la demence senile du type alzheimer

Publications (2)

Publication Number Publication Date
NO20002450D0 true NO20002450D0 (no) 2000-05-11
NO20002450L NO20002450L (no) 2000-07-14

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002450A NO20002450L (no) 1997-11-14 2000-05-11 Sammenstilling av aktive bestanddeler, særlig tetrahydropyridiner og acetylcholinesterase-inhiberende midler, for behandling av senil demens av Alzheimer-type

Country Status (27)

Country Link
EP (1) EP1030671A1 (no)
JP (1) JP2001523642A (no)
KR (1) KR100599350B1 (no)
CN (1) CN1243540C (no)
AU (1) AU743228B2 (no)
BG (1) BG64819B1 (no)
BR (1) BR9814035A (no)
CA (1) CA2309966A1 (no)
CO (1) CO4980891A1 (no)
DZ (1) DZ2649A1 (no)
EA (1) EA003255B1 (no)
EE (1) EE04235B1 (no)
HU (1) HUP0100098A3 (no)
ID (1) ID24933A (no)
IL (2) IL136122A0 (no)
IS (1) IS5482A (no)
MY (1) MY120461A (no)
NO (1) NO20002450L (no)
NZ (1) NZ504420A (no)
OA (1) OA11464A (no)
PL (1) PL194597B1 (no)
SA (1) SA98190747B1 (no)
SK (1) SK286040B6 (no)
TR (1) TR200001262T2 (no)
TW (1) TW585766B (no)
UY (1) UY25247A1 (no)
WO (1) WO1999025363A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4675103B2 (ja) * 2002-06-14 2011-04-20 富山化学工業株式会社 脳機能を改善する医薬組成物および脳機能を改善するための方法
CA2494585A1 (en) * 2002-08-07 2004-02-19 Novartis Ag Methods for the treatment of dementia based on apo e genotype
CN1520818A (zh) * 2003-02-09 2004-08-18 山东绿叶天然药物研究开发有限公司 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物
CA2592605C (en) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
CN106163516B (zh) 2014-01-31 2019-05-28 考格尼申治疗股份有限公司 异吲哚啉组合物和治疗神经变性疾病的方法
CN110869011B (zh) 2017-05-15 2024-01-05 考格尼申治疗股份有限公司 用于治疗神经退行性疾病的组合物
KR102224918B1 (ko) 2018-03-20 2021-03-09 (주)인벤티지랩 도네페질 및 메만틴을 포함하는 인지 장애 관련 질병의 예방 또는 치료용 약학적 복합 조성물 및 이의 제조 방법
WO2019182319A1 (ko) * 2018-03-20 2019-09-26 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
CN109265391B (zh) * 2018-11-13 2021-11-19 枣庄学院 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
JPH11511732A (ja) * 1995-03-06 1999-10-12 インターニューロン ファーマシューティカルズ，インコーポレーテッド シチコリンを用いる梗塞容積の低減
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Also Published As

Publication number Publication date
DZ2649A1 (fr) 2004-12-28
KR20010032099A (ko) 2001-04-16
AU743228B2 (en) 2002-01-24
SA98190747B1 (ar) 2006-11-04
IS5482A (is) 2000-05-09
CA2309966A1 (en) 1999-05-27
TW585766B (en) 2004-05-01
ID24933A (id) 2000-08-31
BG64819B1 (bg) 2006-05-31
IL136122A (en) 2006-07-05
SK286040B6 (sk) 2008-01-07
HUP0100098A2 (hu) 2001-07-30
EA200000412A1 (ru) 2000-12-25
TR200001262T2 (tr) 2001-01-22
BG104428A (en) 2001-08-31
SK7112000A3 (en) 2000-10-09
HUP0100098A3 (en) 2001-12-28
EA003255B1 (ru) 2003-02-27
KR100599350B1 (ko) 2006-07-12
PL340500A1 (en) 2001-02-12
NO20002450L (no) 2000-07-14
AU1160999A (en) 1999-06-07
CN1285742A (zh) 2001-02-28
OA11464A (en) 2003-11-18
IL136122A0 (en) 2001-05-20
EP1030671A1 (fr) 2000-08-30
NZ504420A (en) 2003-08-29
PL194597B1 (pl) 2007-06-29
MY120461A (en) 2005-10-31
EE04235B1 (et) 2004-02-16
EE200000290A (et) 2001-06-15
WO1999025363A1 (fr) 1999-05-27
CO4980891A1 (es) 2000-11-27
JP2001523642A (ja) 2001-11-27
CN1243540C (zh) 2006-03-01
UY25247A1 (es) 2001-05-31
BR9814035A (pt) 2000-09-26

Similar Documents

Publication Publication Date Title
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
DE69612185D1 (de) Bleichverfahren und bleichmittelzusammensetzung
DE69312624D1 (de) Vorrichtung zur unterscheidung von tachykardien und fibrillationen und zur entsprechenden behandlung
DE60022867D1 (de) 1-Arenesulfonyl-2-Aryl-Pyrrolidin und Piperidin Derivative zur Behandlung von CNS-Erkrankungen
ZA964762B (en) Peptidyl heterocycles useful in the treatment of thrombin related disorders.
NO20001412D0 (no) Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
ZA964761B (en) Peptidyl heterocycles useful in the treatment of thrombin related disorders.
NO20002450D0 (no) Sammenstilling av aktive bestanddeler, særlig tetrahydropyridiner og acetylcholinesterase-inhiberende midler, for Õ behandle senil demens av type Alzheimer
HUP0103832A3 (en) Triazolopyridines for the treatment of thrombosis disorders, pharmaceutical compositions containing the same and process for preparation thereof
DE69822676D1 (de) Walzanlage und Walzverfahren
NO995469D0 (no) Fremgangsmåte til behandling av mentale sykdommer hos pattedyr og en sammensetning derfor
IL131085A0 (en) The use of levobupivacaine or ropivacaine in treating migraine
PT1152762E (pt) Utilizacao de desoxipeganina no tratamento da demencia de alzheimer
EP1181308A4 (en) METHODS OF TREATING NEURONAL DEMENTIA ASSOCIATED WITH ATROPHY
DE69802498D1 (de) Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
ATE224711T1 (de) Formulierung zur behandlung und/oder vorbeugung von dementia
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
NO20022990L (no) Fremgangsmåte og sammensetning for behandling av smerte
DE69908572D1 (de) Behandlung von metallen
DE69726054D1 (de) Zellen zur behandlung von demenz
ZA989955B (en) Combination of active ingredients for the treatment of senile dementia of the alzheimer type
HK1028354A (en) Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia